Combination drug regimen may benefit patients with hepatitis C

(The JAMA Network Journals) Treatment of chronic hepatitis C virus genotype 1 infection with the interferon-free regimen of sofosbuvir and ribavirin resulted in a high sustained virologic response rate in a patient population with unfavorable treatment characteristics, according to a study in the August 28 issue of JAMA.
Source: EurekAlert! - Infectious and Emerging Diseases - Category: Infectious Diseases Source Type: news